Arumainathan, Arvind

Dr Arvind Arumainathan

Consultant in Haemato-oncology


Qualifications: MB, ChB (Hons) MRCP FRCPath AFHEA

GMC number: 6052663

Clinics: Royal Liverpool University Hospital

Tumour site(s): Lymphoid malignancy


Profile

Dr Arumainathan completed undergraduate training at the University of Liverpool and the majority of his postgraduate training has been in the Mersey region. Dr Arumainathan’s primary clinical focus is lymphoid malignancy – lymphoma and chronic lymphocytic leukaemia (CLL) – and he has a clinical interest in lymphoma in the setting of immune deficiency. He is the currently the lead for the Trust's Lymphoma Site Reference Group.

Dr Arumainathan participates actively in clinical research and is the local principal investigator for several studies. He is also a clinical co-ordinator for national lymphoma/CLL trials at the Liverpool Cancer Trials Unit. He has been the clinical lead for the integration of haemato-oncology into Clatterbridge since 2015.